INS and schizophrenia: Given the central importance of dopaminergic dysregulation, cognitive deficits, and metabolic dysfunction in schizophrenia (57–59), the potential role of central nervous system insulin signalling in the pathophysiology of schizophrenia is an interesting field to be explored.